BioPharmGuy logo
Sponsored By:
Sponsorship Available
Purchase the BioPharmGuy data
Sinclair Research
XenoPort is defunct.

Fate: Acquired by Arbor Pharmaceuticals, July 2016, $467M


------------------
If you believe any of this information is incorrect, please let us know.